Featured
Sort by
Sort by
30 Sep 2026 • 7:00 AM
Shield Therapeutics - Total Voting Rights
RNS
1 Sep 2026 • 7:00 AM
Shield Therapeutics - Total Voting Rights
RNS
27 Aug 2026 • 4:00 PM
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
RNS
9
20 Aug 2026 • 7:00 AM
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
RNS
1
3 Aug 2026 • 12:02 PM
Shield Therapeutics - Total Voting Rights
RNS
30 Jul 2026 • 7:00 AM
Shield Therapeutics - Q2 and H1 2026 Trading Update
RNS
4
28 Jul 2026 • 7:00 AM
Shield Therapeutics - ACCRUFeR® Phase 3 pediatric trial published
RNS
30 Jun 2026 • 7:52 AM
Shield Therapeutics - Block Listing 6 Monthly Return
RNS
18 Jun 2026 • 4:21 PM
Shield Therapeutics - Results of 2026 Annual General Meeting
RNS
29 May 2026 • 9:11 AM
Shield Therapeutics - Total Voting Rights
RNS